Blink Health, a health IT start-up focused on improving access to prescription medications, raised $90 million in a Series B financing round. The start-up now has a total of $165 million in financing.
Blink Health's technology platform allows consumers to access the medications via the internet. It links consumers to 57,000 pharmacies nationwide, and allows them to buy generic medications online and pick them up from a local retailer for up to 90 percent off the average retail price.
Since its launch in 2014, the company has grown its active users to more than one million per month. The company also offers branded drug programs, including an insulin discount program with Indianapolis-based Eli Lilly. Blink Health will use the new funds to drive innovations.